trimazosin

Known as: 2-hydroxy-2-methylpropyl 4-(4-amino-6,7,8-trimethoxy-2-quinqzolinyl)-1-piperazinecar boxylate, 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-1-piperazinecarboxylic acid, 2-hydroxy-2- methylpropyl ester 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2018
051019732018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
We evaluated chronic adjunctive alpha-1 receptor blockade with trimazosin in congestive heart failure. This agent produced… (More)
Is this relevant?
1983
1983
Trimazosin, a selective alpha-1-adrenoceptor-blocking agent, has been extensively evaluated in over 1000 patients. In… (More)
Is this relevant?
1983
1983
This report describes the clinical hemodynamic response of hypertensive patients to trimazosin. Data were drawn from six… (More)
Is this relevant?
1983
1983
In this study the pharmacokinetics of trimazosin and its major metabolite, CP 23445, were determined, as were also the effects on… (More)
Is this relevant?
1983
1983
The acute and chronic autonomic, systemic, and renal hemodynamic effects of trimazosin and placebo were studied in patients with… (More)
Is this relevant?
1982
1982
The effects of 3 quinazoline alpha-adrenoreceptor antagonists, prazosin, trimazosin, and UK-33,274, on lying blood pressure (BP… (More)
Is this relevant?
1981
1981
Trimazosin, a quinazoline related to the antihypertensive agent prazosin, was studied in anesthetized animals and isolated tissue… (More)
Is this relevant?
1980
1980
Patients with cardiac failure have a generalized sympathetic vasoconstriction that may impair cardiac function and exercise… (More)
Is this relevant?
1979
1979
Because improved long-term oral vasodilator therapy for chronic congestive heart failure is needed, the cardiocirculatory effects… (More)
Is this relevant?
1977
1977
Eighteen patients with hypertension participated in a double-blind, randomized study to evaluate the effect of trimazosin… (More)
Is this relevant?